Perrigo Company plc Gain (Loss) on Extinguishment of Debt
Perrigo Company plc (PRGO) reported Gain (Loss) on Extinguishment of Debt of -$100.00 thousand for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-05
- Perrigo Company plc gain (loss) on extinguishment of debt for the quarter ending 2026-06-27 was -$100.00K.
- Perrigo Company plc gain (loss) on extinguishment of debt for the quarter ending 2026-03-28 was -$1.40M.
- Perrigo Company plc gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- Perrigo Company plc gain (loss) on extinguishment of debt for the quarter ending 2025-09-27 was $0.00.
- Perrigo Company plc gain (loss) on extinguishment of debt for fiscal 2025 was $0.00.
- Perrigo Company plc gain (loss) on extinguishment of debt for fiscal 2024 was -$6.70M, a 309.38% decline from fiscal 2023.
- Perrigo Company plc gain (loss) on extinguishment of debt for fiscal 2023 was $3.20M.
- Perrigo Company plc gain (loss) on extinguishment of debt for fiscal 2022 was -$8.90M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2026-06-27 | -$100.00K 10-Q · filed 2026-08-05 | -$1.40M 10-Q · filed 2026-08-05 | -$1.50M derived: sum of 3 quarters · filed 2026-08-05 | -$1.50M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-28 | -$1.40M 10-Q · filed 2026-05-06 | -$1.40M derived: sum of 2 quarters · filed 2026-05-06 | -$1.40M derived: sum of 3 quarters · filed 2026-05-06 | -$1.40M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-27 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-05 | -$1.50M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-28 | $0.00 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | -$1.50M derived: sum of 3 quarters · filed 2026-08-05 | -$6.60M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-29 | $0.00 10-Q · filed 2026-05-06 | -$1.50M derived: sum of 2 quarters · filed 2026-05-06 | -$6.60M derived: sum of 3 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$6.60M derived: sum of 2 quarters · filed 2026-02-26 | -$6.70M 10-K · filed 2026-02-26 | ||
| 2024-09-28 | -$5.10M 10-Q · filed 2025-11-05 | -$5.20M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.20M derived: sum of 2 quarters · filed 2026-02-26 | $3.20M derived: sum of 3 quarters · filed 2026-02-26 | $3.20M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-07-01 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $400.00K derived: sum of 2 quarters · filed 2025-02-28 | -$8.90M derived: sum of 3 quarters · filed 2025-02-28 | -$8.90M 10-K · filed 2025-02-28 | |
| 2022-10-01 | $400.00K 10-Q · filed 2023-11-07 | -$8.90M derived: sum of 2 quarters · filed 2023-11-07 | -$8.90M 10-Q · filed 2023-11-07 | ||
| 2022-07-02 | -$9.30M 10-Q · filed 2023-08-08 | -$9.30M 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2021-10-02 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-07-03 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$20.00M derived: sum of 2 quarters · filed 2023-02-28 | -$20.00M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$20.00M 10-K · filed 2021-03-01 | ||||
| 2020-09-26 | -$20.00M 10-Q · filed 2021-11-12 | -$20.00M 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$200.00K derived: sum of 2 quarters · filed 2022-03-01 | -$200.00K derived: sum of 3 quarters · filed 2022-03-01 | -$200.00K 10-K · filed 2022-03-01 | |
| 2019-09-28 | -$200.00K 10-Q · filed 2020-11-05 | -$200.00K derived: sum of 2 quarters · filed 2020-11-05 | -$200.00K 10-Q · filed 2020-11-05 | -$200.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-29 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-30 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | -$500.00K 10-K · filed 2021-03-01 | |
| 2018-09-29 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | -$500.00K 10-Q · filed 2019-11-06 | -$500.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | -$500.00K 10-Q · filed 2019-08-08 | -$500.00K derived: sum of 3 quarters · filed 2020-02-27 | -$500.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$500.00K 10-Q · filed 2019-05-09 | -$500.00K derived: sum of 2 quarters · filed 2020-02-27 | -$500.00K derived: sum of 3 quarters · filed 2020-02-27 | -$135.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | -$135.20M derived: sum of 3 quarters · filed 2020-02-27 | -$135.20M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | -$135.20M derived: sum of 2 quarters · filed 2019-02-27 | -$135.20M 10-Q · filed 2018-11-08 | -$135.20M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-07-01 | -$135.20M 10-K · filed 2019-02-27 | -$135.20M 10-Q · filed 2018-08-09 | -$135.20M derived: sum of 3 quarters · filed 2019-02-27 | -$135.90M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-04-01 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | -$700.00K derived: sum of 3 quarters · filed 2019-02-27 | -$700.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$700.00K derived: sum of 2 quarters · filed 2019-02-27 | -$700.00K derived: sum of 3 quarters · filed 2019-02-27 | -$1.10M 10-K · filed 2019-02-27 | |
| 2016-10-01 | -$700.00K 10-Q · filed 2017-11-09 | -$700.00K derived: sum of 2 quarters · filed 2017-11-09 | -$1.10M 10-Q · filed 2017-11-09 | -$2.00M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-07-02 | $0.00 10-Q · filed 2017-08-10 | -$400.00K 10-Q · filed 2017-08-10 | -$1.30M derived: sum of 3 quarters · filed 2018-03-01 | -$1.30M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-04-02 | -$400.00K 10-Q · filed 2017-05-30 | -$1.30M derived: sum of 2 quarters · filed 2018-03-01 | -$1.30M derived: sum of 3 quarters · filed 2018-03-01 | -$2.20M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | -$900.00K derived: 10-K 6 month − 10-Q/A 3 month · filed 2018-03-01 | -$900.00K 10-K · filed 2018-03-01 | -$1.80M derived: sum of 3 quarters · filed 2018-03-01 | -$1.80M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-09-26 | $0.00 10-Q/A · filed 2017-05-23 | -$900.00K derived: sum of 2 quarters · filed 2017-05-23 | -$900.00K 10-Q/A · filed 2017-05-23 | -$10.50M derived: sum of 4 quarters · filed 2017-05-23 | |
| 2015-06-27 | -$900.00K 10-Q/A · filed 2017-05-22 | -$900.00K 10-Q/A · filed 2017-05-22 | -$10.50M derived: sum of 3 quarters · filed 2017-05-22 | -$10.50M 10-K · filed 2018-03-01 | |
| 2015-03-28 | $0.00 10-Q/A · filed 2017-05-22 | -$9.60M derived: sum of 2 quarters · filed 2017-05-22 | -$9.60M 10-Q · filed 2015-04-29 | ||
| 2014-12-27 | -$9.60M 10-K · filed 2017-05-22 | -$9.60M 10-K · filed 2018-03-01 | |||
| 2014-06-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $0.00 derived: sum of 2 quarters · filed 2017-05-22 | $165.80M derived: sum of 3 quarters · filed 2017-05-22 | -$165.80M 10-K · filed 2017-05-22 | |
| 2014-03-29 | $0.00 10-Q · filed 2015-04-29 | $165.80M derived: sum of 2 quarters · filed 2016-02-25 | -$165.80M 10-Q · filed 2015-04-29 | ||
| 2013-12-28 | $165.80M 10-KT · filed 2016-02-25 | -$165.80M 10-Q · filed 2014-02-06 | -$165.80M 10-Q · filed 2015-02-05 | ||
| 2013-06-29 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 10-KT · filed 2016-02-25 | |
| 2013-03-30 | $0.00 10-Q · filed 2014-05-07 | $0.00 derived: sum of 2 quarters · filed 2014-05-07 | $0.00 10-Q · filed 2014-05-07 | ||
| 2012-12-29 | $0.00 10-Q · filed 2014-02-06 | $0.00 10-Q · filed 2014-02-06 | |||
| 2012-06-30 | $0.00 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |